44, Kifissias Avenue, 151 25
30 210 66 04 300
30 210 66 66 749
Pharmathen is a research-oriented company aiming at the development of high quality pharmaceutical products both in the field of generics and innovative finished formulations. Pharmathen invests more than €20 million annually in Research and Development, developing 10-12 new generic molecules per year. In addition Pharmathen develops 3-4 projects of innovative formulations every year concerning mainly the development of advanced pharmaceutical and drug delivery technologies as well as their application in selected drug substances. With the application of innovative techniques and advanced technologies, Pharmathen aims to provide challenging solutions LCM of brand companies as well as to develop and establish new technology platforms and provide optimized pharmaceutical products to patients.
CFO: Panagiotis Georgalas
Please click here for Pharmathen job opportunities.